(Q48375814)

English

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .

scientific article published in September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane . (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

Michael D. B. Swedberg

11

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

author name string

F P Bymaster

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

H E Shannon

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

K Rasmussen

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

N W Delapp

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

C H Mitch

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

J S Ward

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

D O Calligaro

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

T S Ludvigsen

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

M J Sheardown

9

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

P H Olesen

10

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

P Sauerberg

12

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

A Fink-Jensen

13

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

European Journal of Pharmacology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

356

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

2-3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

109-119

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Comparison of second-messenger responses to muscarinic receptor stimulation in M1-transfected A9 L cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Central cholinergie blockade of the conditioned avoidance response in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Climbing behaviour induced by apomorphine in mice: A potential model for the detection of neuroleptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of alpha 1-adrenergic or 5HT2 receptor blockade to haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Molecular cloning, stable expression and desensitization of the human dopamine D1b/D5 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Choline acetyltransferase in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Stimulus-transcription coupling in neurons: role of cellular immediate-early genes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Expression of c-fos protein in brain: metabolic mapping at the cellular level

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Dopamine D4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Schizophrenia and Alzheimer's disease: clinical and pathophysiologic analogies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900487-7

7 January 2021

Identifiers

10.1016/S0014-2999(98)00487-7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9774240

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48375814&oldid=1373068290"